Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Meredith M Regan, Sc.D.

Co-Author

This page shows the publications co-authored by Meredith Regan and Charlene Mantia.
Connection Strength

1.468
  1. Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors. Melanoma Res. 2022 02 01; 32(1):35-44.
    View in: PubMed
    Score: 0.984
  2. Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial. Clin Cancer Res. 2021 12 15; 27(24):6687-6695.
    View in: PubMed
    Score: 0.242
  3. Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067. J Immunother Cancer. 2021 11; 9(11).
    View in: PubMed
    Score: 0.242
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.